Sub-Q Bionics vs XCath
Sub-Q Bionics vs XCath, compared side by side on 12 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Sub-Q Bionics is on 33/100 and XCath on 54/100.
Where each one leads
Sub-Q Bionics
Leads on none of the measures we hold for both companies.
XCath
- our overall score: 54/100 against 33/100
- funding raised: $54.0M against $1.5M
At a glance
| Measure | Sub-Q Bionics | XCath |
|---|---|---|
| What it is | Developing next-generation solutions to improve care for patients living with lymphedema. | Pioneering neuro-endovascular surgical robotics for precise, remote-controlled treatment of brain aneurysms and strokes. |
| Category | Medical Devices, Biotechnology, HealthTech | Medical Devices, Robotics, Healthcare, Biotechnology |
| Sells toBusiness model | B2B | B2B |
| Offering | Hardware | Hardware |
| Founded | Not published | 2017 |
| Headquarters | Stillwater, USA | Houston, United States |
| Status | Active | Active |
Size, funding and growth
| Measure | Sub-Q Bionics | XCath |
|---|---|---|
| Employees | Not published | 31 |
| Total funding | $1.5M | $54.0M |
| Latest round | Pre-Seed | Series C |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Sub-Q Bionics | XCath |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 33/100 | 54/100 |
| Traction | 31/100 | 54/100 |
| Team | Not published | 30/100 |
| Search visibility | 15/100 | 9/100 |
| Quality | 45/100 | 68/100 |
| Agent readinessHow well an AI agent can read and act on the site | Not published | D (41/100) |
| Domain ratingLink authority, 0-100 | Not published | 12/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Sub-Q Bionics | XCath |
|---|---|---|
| CDN | Not detected | Fastly |
| Frameworks | Not detected | Jquery, Tailwind CSS, Bootstrap |
Sub-Q Bionics vs XCath: common questions
Which is better, Sub-Q Bionics or XCath?
On our 0-100 score XCath rates higher (54/100 against 33/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 12 data points above: read the rows that match what you are buying for.
How do Sub-Q Bionics and XCath compare on the numbers?
XCath leads on our overall score (54/100 against 33/100), funding raised ($54.0M against $1.5M).
Read the full Sub-Q Bionics review and pricing or the XCath review and pricing. You can also browse other Sub-Q Bionics alternatives we track.